Table 2: The effect of pequi oil compared to placebo in patients with SLE in several variables.

Variables

Δ (initial - final)

Difference between groups

 

P-values

Placebo Group

Pequi oil

Placebo - Pequi oil

DNA damage index

0.54 1.45

1.68 1.45

-1.42 1.74

0.5818

SLEDAI

0.12 0.81

-1.01 0.88

1.12 1.14

0.3598

BMI

0.13 0.11

0.15 0.11

-0.02 0.14

0.8884

WC

0.47 0.64

-0.01 0.64

0.48 0.73

0.5994

HC

0.28 0.42

0.73 0.44

-0.45 0.60

0.4632

W/H

0.00 0.01

-0.00 0.01

0.01 0.01

0.4626

AC adequacy

-0.01 0.54

0.46 0.54

-0.47 0.74

0.5460

TS adequacy

1.24 1.87

3.43 1.87

-2.18 2.65

0.4164

AMC adequacy

-0.24 0.70

-0.47 0.70

0.23 1.00

0.8172

Glucose

-0.59 3.21

1.03 2.01

-1.62 3.23

0.6805

AST

-0.14 1.33

-0.81 1.27

0.67 1.79

0.7192

ALT

0.48 1.47

-0.85 1.40

1.33 1.99

0.5180

GGT

-6.07 2.00

-3.98 1.28

-2.08 2.38

0.4092

hs-CRP

-0.07 0.06

0.15 0.06

-0.22 0.08

0.0161*

Uric acid

0.41 0.25

0.06 0.19

0.34 0.26

0.2963

Total cholesterol

2.74 3.50

-3.26 3.42

5.70 4.76

0.2339

Triglycerides

12.71 5.84

-0.03 5.71

12.75 7.88

0.1327

HDL

0.13 1.36

-2.25 1.32

2.38 1.84

0.2218

LDL

0.15 3.23

-0.90 3.15

1.05 4.37

0.8190

VLDL

2.44 1.49

0.01 1.22

2.43 1.56

0.1440

Globulin

-0.02 0.08

-0.01 0.07

-0.01 0.10

0.9280

 

SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; BMI: Body Mass Index; WC: Waist Circumference; HC: Hip Circumference; W/H: Waist/hip ratio; AC: Arm Circumference; TS: Triceps Skinfold thickness; AMC: Arm Muscle Circumference; AST: Aspartate Transaminase; ALT: Alanine aminotransferase; GGT: Gamma-Glutamyl Transferase; hs-CRP: High-Sensitivity C-reactive protein (hs-CRP); HDL: High-Density Lipoprotein; LDL: Low Density Lipoprotein; VLDL: Very Low Density Lipoprotein; *p-value with statistical significance. Values expressed as mean standard least squares error.